The 2010 McDonald criteria for multiple sclerosis can be used in children older than 10 who do not present with acute disseminated encephalomyelitis.
The 2010 McDonald criteria for multiple sclerosis (MS) simplified the imaging criteria in adults who present with a typical demyelinating event (JW Neurol Jan 25 2011). The 2010 criteria maintained high sensitivity and specificity while reducing the required number of T2 lesions and permitting the MS diagnosis when there are “clinically silent,” simultaneous gadolinium-enhancing and nonenhancing lesions.
Investigators have now tested the 2010 criteria in children younger than 16 who presented with an acute demyelinating event at 23 centers. Participants were enrolled within 90 days of symptom onset and followed for a mean 4.2 years. All had magnetic resonance imaging scans at baseline and 3, 6, and 12 months later; many had subsequent annual…
Reviewing Author
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)
DisclosuresConsultant/Advisory BoardAlexion Pharmaceuticals; Amgen; Astoria; Biogen; Bristol Myers Squibb; Celltrion; Genentech; Hoffmann-La Roche; Genzyme; EMD Serono; Immpact-Bio; Immunic Therapeutics; Kyverna; Lundbeck; Novartis; Sandoz; TG Therapeutics
Grant/Research SupportNational Institutes of Health; National Multiple Sclerosis Society; U.S. Department of Defense
Leadership Positions in Professional SocietiesConsortium of Multiple Sclerosis Centers (Treasurer)